Atherosclerosis, autoimmunity, and systemic lupus erythematosus.
- 16 October 2001
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 104 (16) , 1876-7
- https://doi.org/10.1161/circ.104.16.1876
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunctionMolecular Aspects of Medicine, 2000
- Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunityJournal of Clinical Investigation, 2000
- Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.Journal of Clinical Investigation, 1998
- Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.Journal of Clinical Investigation, 1996
- The oxidation hypothesis of atherosclerosisThe Lancet, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation.The Journal of Experimental Medicine, 1988
- Diversity in the germline antibody repertoire. Molecular evolution of the T15 VN gene family.The Journal of Experimental Medicine, 1985
- Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae.The Journal of Experimental Medicine, 1982
- Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids.The Journal of Experimental Medicine, 1981